Subsequently, we evaluated the DEGs related to the immune score and the stromal score and determined the prognosis-related genes from the clinicopathological data, and we identified CXCL10 and CXCL11 as prognostic factors in the pancreatic cancer TME. This evidence concerns the gene CXCL11 and familial pancreatic carcinoma.